Objectives: The aim of this paper was to describe an increased occurrence of vancomycin-resistant enterococci (VRE) in Swedish broilers since 2000 and to investigate the genetic relatedness of isolates.
Introduction
The glycopeptide vancomycin is an antimicrobial that, in human medicine, is primarily used to treat infections with Grampositive bacteria resistant to other antimicrobials. Enterococci are ubiquitous microorganisms and are a part of the normal intestinal flora of man and many other animals. Traditionally, enterococci were considered to be low-grade pathogens with little clinical relevance. During the last two decades, this has changed and they are now increasingly important as opportunistic pathogens causing nosocomial infections in immunocompromised patients. 1 An increasing proportion of these infections are caused by vancomycin-resistant enterococci (VRE) first isolated in 1986. 1, 2 In the 1990s, Enterococcus faecium carrying the vanA gene, i.e. VRE, were common in the intestinal flora of farm animals in Europe, mainly due to the extensive use of the glycopeptide growth promoter avoparcin. 3 When the association between avoparcin and VRE was confirmed, its use was discontinued, first in Denmark, Finland and Norway and eventually, in 1997, in the whole of the European Union (Commission Directive 97/6 EC).
The main reason for this was to evade a pool of VRE that could potentially spread into the community and further into hospital settings. 1 After the withdrawal of avoparcin, the prevalence of VRE in farm animals in Europe rapidly declined. 4 In Sweden, no growth promoters have been used since 1986, and the use of avoparcin was discontinued even before that. Avoparcin was only used for some years in the late 1970s and early 1980s at quantities of about eight tons per year. 5 Consequently, the situation in Sweden differed from that in other European countries, and VRE were not isolated in samples from Swedish broilers in the middle of the 1990s. 6 Using medium supplemented with vancomycin, VRE were isolated from the intestinal contents from 4 of 150 broilers and 1 of 306 pigs in a survey conducted from 1998 to 2000. 7 Since 2000, the presence of VRE in the intestinal contents from broilers and other farm animals has been regularly monitored as part of the Swedish Veterinary Antimicrobial Resistance Monitoring (SVARM) programme. 8 In this programme, VRE have not been isolated from pigs or cattle and only rarely in samples from broilers when medium without vancomycin was used for bacteriological culture. However, since 2000, VRE have been isolated from an increasing proportion of samples from broilers when medium supplemented with vancomycin was used. The aim of this paper was to describe this increase and to investigate the genetic relatedness of isolates. 
Materials and methods

Sampling
Bacterial isolation and identification
Caecal content (0.5 g) was suspended in 4.5 mL of saline from which 0.1 mL was streaked on Slanetz -Bartley agar (Oxoid, Basingstoke, UK) supplemented with vancomycin (Sigma-Aldrich, Steinheim, Germany) and incubated at 378C for 48 h. From plates with growth of colonies typical for enterococci, at least one colony was subcultured on blood agar (Oxoid) and Bile-Esculine agar (Oxoid) and incubated at 378C for 24 h. Presumptive enterococci were identified to species level according to Devriese et al. 9 Isolates were stored at 2708C for further investigations.
Susceptibility testing
Susceptibility against a panel of antimicrobials (Table 2) was tested by the determination of MIC using microdilution methods according to the standards of the CLSI. 10 The Enterococcus faecalis reference strains ATCC 29212 and ATCC 33186 were used for quality control. The tests were performed using cation-adjusted MuellerHinton broth (Difco, Sparks, USA) using VetMIC TM E-cocci panels (SVA, Uppsala, Sweden). Susceptibility data were interpreted according to epidemiological cut-off values suggested by EUCAST (http://www.eucast.org), except for narasin where a cut-off of .2 mg/L was used instead of the recommended value of .4 mg/L. Isolates with MICs above the wild-type cut-off value were considered resistant.
Investigation of resistance genotype
In a subset of isolates, the gene encoding vancomycin resistance was determined using PCR for the vanA gene. 
Multilocus sequence typing (MLST)
To determine the genetic relatedness of VRE isolates, MLST was performed as described previously by Homan et al., 12 with modifications as described on the MLST web site (http://www.mlst.net). In total, 48 VRE isolates from Swedish broilers were analysed, including the first 2 isolates from 2000 and 46 isolates selected at random from the total of 338 isolates obtained from January 2001 until June 2007.
Tn1546 transposon typing
For the 48 VRE isolates typed by MLST, the vanA-containing Tn1546 transposon was typed using an overlapping PCR method modified from Woodford et al. 13 Briefly, the primers were adjusted (Table 1) , and a touchdown PCR strategy was employed using HotStarTaq master mix (Qiagen GmbH, Germany). The initial denaturation step of 15 min at 958C was followed by 10 cycles consisting of 30 s at 948C, 30 s at 618C down to 518C and 1 min at 728C, followed by 30 cycles of 30 s at 948C, 30 s at 518C and 1 min at 728C, GCT ATT GGA GCG ACA GAC A GCG GAT TTA CAA CGT TAA G with a final extension step of 7 min at 728C. BM4147 was included as a positive control. The result was visualized by running the PCR products on a 1% agarose gel with 0.01% ethidium bromide.
Statistical analysis
Differences in the proportion of VRE-positive samples between years were tested with Pearson's x 2 test using Stata software (release 10, Stata, College Station, TX, USA). Resistance phenotype and genotype All VRE were high-level vancomycin-resistant (MIC.64 mg/L), and all isolates investigated by PCR (n ¼ 117) carried the vanA gene. In addition, the majority of isolates (89.6%) had a phenotype also including resistance to narasin (MIC 4 -16 mg/L) and erythromycin (MIC 8-16 mg/L) ( Table 2) . A minority of isolates had other resistance phenotypes ( 
Results
VRE isolation and identification
Tn1546 transposon typing
All investigated isolates rendered PCR products for all 10 primer pairs, and the products for each primer pair were of the same size for all the isolates. The profile of the investigated strains was the same as that of BM4147, indicating identical Tn1546 transposons ( Figure 2 ).
Discussion
Since 2000, the proportion of VRE-positive samples from Swedish broilers has increased considerably. MLST analysis revealed that this is due to the spread of one major clone of E. faecium carrying the same Tn1546 type. The increase is evident when vancomycin-supplemented medium is used, but there is no apparent change in the prevalence of vancomycin resistance among randomly selected E. faecium. 8 This indicates that only a small proportion of enterococci in the intestinal flora of broilers are VRE. This is in contrast to the course of events in other parts of Europe. When avoparcin was still in use during the 1990s, up to 80% of randomly selected E. faecium from broilers were vancomycin-resistant.
14 After the withdrawal of avoparcin in Europe, there was a sharp reduction in the proportion of VRE among randomly selected E. faecium from intestinal contents. 15 This indicates a decline in actual numbers. However, a high prevalence of VRE is still found in broilers when medium supplemented with vancomycin is used. 16 In Sweden, avoparcin has not been used since the early 1980s, and the prevalence of VRE among Swedish broilers and their possible clonality at that time are not known in detail. In studies from the late 1990s, only occasional isolates of VRE were found. 6, 7 Also the diversity of the VRE population among broilers is different between Sweden and the rest of Europe. In Europe, several different strains of VRE have been isolated, even on the same farm and sampling occasion. 17 This is in contrast to the apparent clonality of isolates from Swedish broilers shown by MLST in this study.
In Sweden, there is currently no obvious selection pressure for VRE in broiler production. Avoparcin has, as previously mentioned, not been used since the early 1980s, indicating that vancomycin resistance per se is not the selective advantage of the clone. Ionophores are commonly used for prophylaxis against coccidiosis, but selection for VRE by this use is unlikely since ionophore resistance is widespread also among vancomycinsusceptible enterococci from Swedish broilers. 8 Moreover, therapeutic use of antimicrobials is rare in Swedish broiler production. Instead, the emphasis is on disease control by biosecurity, including hygiene barriers and a strict all-in all-out procedure.
The increase in the proportion of VRE-positive samples since 2000 could be explained by the introduction of VRE or the emergence of a very competitive strain, in the late 1990s.
Alternatively, there could have been changes in management at that time favouring persistence and transmission of VRE. Yet another scenario is that the explanation lies in a combination of these factors. The fact that only three different MLST STs have been documented indicates that VRE in Swedish broilers did not emerge due to selective pressure by avoparcin, i.e. there has probably been an introduction at some point after the withdrawal of avoparcin. That the two STs found in 2000 (ST13 and ST370) were not re-isolated indicates that glycopeptide resistance is not the selective advantage of the dominating clone (ST310).
The reason for discontinuing the use of avoparcin in the EU was to avoid a pool of resistance genes among farm animals that could, via the food chain, influence the situation in human medicine. The potential for such an influence was indirectly indicated by the reduced prevalence of VRE in healthy humans observed after the withdrawal of avoparcin. 15 Since only a small proportion of enterococci in the intestinal flora of broilers are VRE, and since chicken meat is normally thoroughly heat-treated before consumption, the risk of such a spillover in Sweden is low. Infections caused by VRE are still uncommon in Sweden and, in addition, the majority of human cases are caused by E. faecium carrying the vanB gene.
18 Therefore, the presence of VRE among Swedish broilers does not seem to have affected the situation within Swedish healthcare. Nor is it clear if the situation in the community is affected. Two separate studies on sewage, as an indicator of community carriage, gave contradictive results with 5% and 54% of VRE, respectively, being E. faecium carrying the vanA gene.
19, 20 Nevertheless, a pool of resistance genes in production animals is unwanted. Therefore, studies aimed at counteracting the spread and persistence of ST310 are warranted. This includes identifying routes of spread and possible selective pressures, as well as selective advantages of ST310.
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